Member Info for Matml74

some new posters here want you to think see’s large holders are selling in the background.

there have been no changes in the significant institutional holdings for years. ignore their bull****e.

lombard odier asset management (europe) 15.53%

federated hermes 8.63%

vs international venture 8.92%

herald investment management 4.73%

richard griffiths and family 3.30%

toronado partners 2.60%

killik & co 2.47%

doubt you will find another aim stock with such strong institutional support.

Great post. Agree fully.

😂😂😂

You two literally are the stupidest tag team I have seen on LSE and that is saying something.

Broke said two days ago “ I believe 1p is the next target!”

….. and then there is this cracker…. “ Yes I am down 80% on this dog having bought over 12p”

Today he bought below 2p and is being patient.

Get back to class children 😂😂

😂😂😂

Thank god there are people on the planet like you to save them all.

So kind of you to waste your days looking out for other peoples money.

😂 you seem to neglect the 1.9p to 13.5p increase in 2020-2021 which some of us rode and made a killing out of.

Think we are about to go on that ride again so load up and stop being a miserable prick.

GSR regulation starts July 2026.

NCAP ratings start 1st January 2026

So OEM’s can get ahead of GSR and get 5 star ratings from that point…… if they have decent dms.

For anyone that bothers to read the protocol and understand it, they might start to realise that there is one company whose R&D effectively underpins the NCAP dms protocol assessment criteria…..

“ The safest and most reliable DMS are those that can detect driver eye movements in addition to head movements. Head pose is still an important input to measuring driver gaze direction—for example, it is a useful and necessary surrogate for glances that go beyond 60 degrees horizontally in relation to the DMS sensor. However, DMS that is unable to track eye behaviour will fail to protect road users against one of the most dangerous and prolific behaviours that a driver can engage in—cellphone use.”

https://seeingmachines.com/lizard-glances-the-achilles-heel-of-dms-that-rely-on-head-pose/

he’s jot a journalist, it’s an blog by an pi, a bit like that twat you trolls were posting like gospel last week who had the opposite view of see.

everyone knows safestocks holds stock in see, which he openly admits. most people are intelligent enough to understand this build that context into his comments but you obviously aren’t.

give up because noone is falling for your ****.

I posted this last week and some troll got it deleted.

In the FY presentation the company said they have non dilutive financing in place if required.

Again today, Martin Ive, previously the highly successful CFO of Altrium, which sold last year A$9.1 billion, has told investors that NON DILUTIVE funding will be used if they need any cash before cash flow breakeven which is coming within the next 7 months.

Do not listen to ignorant trolls who do not understand even the basics of the incoming companies revenue growth generation.

wrong. you have very little understanding of this company so give your constant trolling.

they call out 100% yoy growth. so hit that.

also q1 is always impacted by oem seasonality production. but a lazy ****e investors like you wouldn’t bother to try and understand that.

“seasonality of automotive production impacted the quarter-on-quarter growth rate, similarly to q1 fy2023.”

.

He also know’s what Magna are going to do with a CLN which is not due for over 2 years. You know the company that has a deep collaboration with SEE and a significant shareholding already….. but this LSE trader knows exactly what Magna will do.

Look out SEE shareholders DILUTION is coming TRUST ME.

BV,

It wasn’t related to ADC’s. Anthracycline treatment in TNBC often results in pulmonary adverse events so comment was around that.

Pretty hard to buy in a closed period.

Directors have bought heaps over the last few years. Find me another AIM stock where directors have bought anything like they have in SEE and you will be doing well.

1m shares traded in a day ( a minute fraction of shares in issue) and a tiny UT below the bid suggests nothing apart from people are willing to hold and wait.

Not one of the large institutional shareholders (whom hold the majority of SEE stock) have sold any stock in years. They tend to look at fundamentals and the biggest picture rather than daily SP. It can do wonders for people’s confidence in their investments.

AIM market is broken Boygo. Unless the stock has the liquidity for small time traders to make their 10% then there is no institutional interest in AIM companies no matter their underlying fundamentals.

SEE needs to deliver on its projections ($300m in auto revenues banked by FY2028), develop its other verticles and then get onto the main market once profitable or package up and sell to Magna/valeo or a larger entity.

Next few years make this investment. PMG and MI time to deliver. I am happy to wait it out based on regulatory push and IP lead.

Why are you invested then?

Look out Einstein has arrived.

😂 investors chronicle. Author should have read the full Peel Hunt note. Who would recommend sell when PH suggest 100%+ upside in 12 months. Quality journalism.

“ Today, Peel Hunt analyst Oliver Tipping confirmed that view: “Greater demand for low-priced ‘basic’ DMS and the delay in getting its Gen 3 aftermarket product ready to ship, mean FY24 margins are lower than expected. Underlying progress remains solid, today’s acquisition further differentiates its expertise, and the EU regulations mandating more advanced DMS (at a higher ASP) in 2026 keep us bullish on the medium term prospects. We revise our numbers based on this shift to the right and lower our 12-month TP from 12p to 9p, but retain our Buy rating.”

Okay Nathan. Create whatever fantasy you want. It’s possible if you really want it to be.

Things is other company’s are going to win 60% of the dms market potentially. SEE have told us that.

Understand that SEE will take 50% by value, understand what that means for their future growth and decide whether that is a worthy investment. I personally do not see the point in caring whether SEYE might work with Gentex or anyone else for that matter.